Literature DB >> 15857609

Regulation of dense core vesicle release from PC12 cells by interaction between the D2 dopamine receptor and calcium-dependent activator protein for secretion (CAPS).

Alicia V Binda1, Nadine Kabbani, Robert Levenson.   

Abstract

We identified CAPS1 (calcium-dependent activator protein for secretion) as a D2 dopamine receptor interacting protein (DRIP) in a yeast two-hybrid screen of a human brain library using the second intracellular domain of the human D2 receptor (D2IC2). CAPS1 is an evolutionarily conserved calcium binding protein essential for late-stage exocytosis of neurotransmitters from synaptic terminals. CAPS1 interaction was confirmed for both the long and short isoforms of the D2 receptor, but not with any other dopamine receptor subtype. Interaction between CAPS1 and the D2 receptor was validated using both pulldown and coimmunoprecipitation assays. Deletion mapping localized the D2 receptor binding site to a segment located within the C-terminal region of CAPS1 as well CAPS2. In PC12 cells, CAPS1 and D2 receptors were found to colocalize within both cytosolic and plasma membrane compartments. Overexpression of a truncated D2 receptor fragment caused a significant decrease in K(+)-evoked dopamine release from PC12 cells, whereas no effect on norepinephrine or BDNF release was observed. These results suggest that D2 dopamine receptors may modulate vesicle release from neuroendocrine cells via direct interaction with components of the exocytotic machinery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857609     DOI: 10.1016/j.bcp.2005.02.015

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

1.  CAPS1 Suppresses Tumorigenesis in Cholangiocarcinoma.

Authors:  Shuqiang Weng; Harry L A Janssen; Ningping Zhang; Wenqing Tang; Encheng Bai; Biwei Yang; Ling Dong
Journal:  Dig Dis Sci       Date:  2019-09-27       Impact factor: 3.199

2.  Candidate genes in quantitative trait loci associated with absolute and relative kidney weight in rats with Inherited Stress Induced Arterial Hypertension.

Authors:  Olga E Redina; Svetlana E Smolenskaya; Leonid O Klimov; Arcady L Markel
Journal:  BMC Genet       Date:  2015-02-02       Impact factor: 2.797

3.  Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients.

Authors:  Tetsushi Sadakata; Miwa Washida; Yoshimi Iwayama; Satoshi Shoji; Yumi Sato; Takeshi Ohkura; Ritsuko Katoh-Semba; Mizuho Nakajima; Yukiko Sekine; Mika Tanaka; Kazuhiko Nakamura; Yasuhide Iwata; Kenji J Tsuchiya; Norio Mori; Sevilla D Detera-Wadleigh; Hironobu Ichikawa; Shigeyoshi Itohara; Takeo Yoshikawa; Teiichi Furuichi
Journal:  J Clin Invest       Date:  2007-03-22       Impact factor: 14.808

Review 4.  Developmentally regulated Ca2+-dependent activator protein for secretion 2 (CAPS2) is involved in BDNF secretion and is associated with autism susceptibility.

Authors:  Tetsushi Sadakata; Teiichi Furuichi
Journal:  Cerebellum       Date:  2009-02-24       Impact factor: 3.847

5.  Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence.

Authors:  Jay Jin; Saranya Kittanakom; Victoria Wong; Beverly A S Reyes; Elisabeth J Van Bockstaele; Igor Stagljar; Wade Berrettini; Robert Levenson
Journal:  BMC Neurosci       Date:  2010-03-09       Impact factor: 3.288

6.  Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization.

Authors:  Min Wang; Lin Pei; Paul J Fletcher; Shitij Kapur; Philip Seeman; Fang Liu
Journal:  Mol Brain       Date:  2010-09-02       Impact factor: 4.041

7.  Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3.

Authors:  Loreto A Egaña; Rolando A Cuevas; Tracy B Baust; Leonardo A Parra; Rehana K Leak; Sarah Hochendoner; Karina Peña; Marisol Quiroz; Weimin C Hong; Mario M Dorostkar; Roger Janz; Harald H Sitte; Gonzalo E Torres
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

8.  Reduced axonal localization of a Caps2 splice variant impairs axonal release of BDNF and causes autistic-like behavior in mice.

Authors:  Tetsushi Sadakata; Yo Shinoda; Megumi Oka; Yukiko Sekine; Yumi Sato; Chihiro Saruta; Hideki Miwa; Mika Tanaka; Shigeyoshi Itohara; Teiichi Furuichi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-03       Impact factor: 11.205

9.  Interaction with dopamine D2 receptor enhances expression of transient receptor potential channel 1 at the cell surface.

Authors:  Meredith A Hannan; Nadine Kabbani; Constantinos D Paspalas; Robert Levenson
Journal:  Biochim Biophys Acta       Date:  2008-01-18

10.  Alternative splicing variations in mouse CAPS2: differential expression and functional properties of splicing variants.

Authors:  Tetsushi Sadakata; Miwa Washida; Teiichi Furuichi
Journal:  BMC Neurosci       Date:  2007-04-12       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.